Preoperative detection of hepatocellular carcinoma: Ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging

American Journal of Roentgenology

Volumn 179, Issue 3, 2002, Pages 741-750

  Kim, Seung Kwon ^a   Kim, Seung Hoon ^a   Lee, Won Jae ^a   Kim, Hana ^a   Seo, Jung Wook ^a   Choi, Dongil ^a   Lim, Hyo K ^a   Lee, Soon Jin ^a   Lim, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SIGNAL NOISE RATIO;

EID: 0036721540     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.3.1790741     Document Type: Article

References (32)

1. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver
2. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions
3. MR imaging with IV superparamagnetic iron oxide: Efficacy in the detection of focal hepatic lesions
4. Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging
5. Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging
6. Preoperative detection of hepatocellular carcinoma: Ferumoxides-enhanced MR imaging versus combined CT during arterial portography and CT hepatic arteriography
7. Detection of malignant hepatic tumors: Comparison of gadolinium- and ferumoxide-enhanced MR imaging
8. Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis
9. Detection and segmental location of malignant hepatic tumors: Comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging
10. Focal hepatic lesion detection: Comparison of four fat-suppressed T2-weighted MR imaging pulse sequences
11. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: Importance of Kupffer cell number
12. Hepatic MR imaging with Mn-DPDP: Safety, image quality, and sensitivity
13. Diagnostic efficacy of MnDPDP in MR imaging of the liver: A phase III multicentre study
14. MnDPDP for MR imaging of the liver: Results from the European phase III studies
15. Hepatocellular tumors: Characterization with Mn-DPDP-enhanced MR imaging
16. Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images
17. Benign and malignant hepatocellular tumors: Evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging
18. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)
19. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis
20. Efficacy and safety of mangafodipir trisodium (MnD-PDP) injection for hepatic MRI in adults: Results of the U.S. multicenter phase III clinical trials - Efficacy of early imaging
21. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP)
22. Superparamagnetic iron oxide: Pharmacokinetics and toxicity
23. Surgical anatomy and anatomical surgery of the liver
24. Some practical issues of the experimental design and data analysis in radiological ROC studies
25. The meaning and use of the area under a receiver operating characteristic (ROC) curve
26. The measurement of observer agreement for categorical data
27. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis
28. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver
29. Detection of hepatic lesions in candidates for surgery: Comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT
30. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? prologue to a promising future
31. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography